144 related articles for article (PubMed ID: 16888681)
1. Dual androgen-response elements mediate androgen regulation of MMP-2 expression in prostate cancer cells.
Li BY; Liao XB; Fujito A; Thrasher JB; Shen FY; Xu PY
Asian J Androl; 2007 Jan; 9(1):41-50. PubMed ID: 16888681
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
3. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells.
Gavrielides MV; Gonzalez-Guerrico AM; Riobo NA; Kazanietz MG
Cancer Res; 2006 Dec; 66(24):11792-801. PubMed ID: 17178875
[TBL] [Abstract][Full Text] [Related]
4. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
5. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
6. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A
Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
8. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
[TBL] [Abstract][Full Text] [Related]
9. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
[TBL] [Abstract][Full Text] [Related]
10. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
Wang CH; Chang HC; Hung WC
J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
[TBL] [Abstract][Full Text] [Related]
11. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration.
Séguin CA; Pilliar RM; Madri JA; Kandel RA
Spine (Phila Pa 1976); 2008 Feb; 33(4):356-65. PubMed ID: 18277865
[TBL] [Abstract][Full Text] [Related]
14. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the TGF-beta1 promoter by androgen receptor.
Qi W; Gao S; Wang Z
Biochem J; 2008 Dec; 416(3):453-62. PubMed ID: 18651839
[TBL] [Abstract][Full Text] [Related]
16. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
[TBL] [Abstract][Full Text] [Related]
18. Induction of human matrix metalloproteinase-12 gene transcriptional activity by GM-CSF requires the AP-1 binding site in human U937 monocytic cells.
Wu L; Tanimoto A; Murata Y; Fan J; Sasaguri Y; Watanabe T
Biochem Biophys Res Commun; 2001 Jul; 285(2):300-7. PubMed ID: 11444842
[TBL] [Abstract][Full Text] [Related]
19. Androgen regulation of the human ornithine decarboxylase promoter in prostate cancer cells.
Bai G; Kasper S; Matusik RJ; Rennie PS; Moshier JA; Krongrad A
J Androl; 1998; 19(2):127-35. PubMed ID: 9570735
[TBL] [Abstract][Full Text] [Related]
20. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
